Literature DB >> 17017202

Bilateral CRAO and CRVO from thrombotic thrombocytopenic purpura: OCT findings and treatment with triamcinolone acetonide and bevacizumab.

Stephen G Schwartz1, Marcela Hickey, Carmen A Puliafito.   

Abstract

A patient with thrombotic thrombocytopenic purpura secondary to adult-onset Still's disease presented with bilateral combined central retinal artery occlusion and central retinal vein occlusion, a rare complication reported only once before. Fundus appearance and fluorescein angiography were similar to the previous case. Optical coherence tomography findings demonstrated aspects consistent with both central retinal artery occlusion and central retinal vein occlusion. Treatment of one eye with intravitreal triamcinolone acetonide (4 mg) was not effective in improving visual acuity. Treatment of both eyes with intravitreal bevacizumab (1.25 mg) and panretinal photocoagulation was effective in eliminating iris neovascularization, although the patient lost all visual function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17017202     DOI: 10.3928/15428877-20060901-10

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  9 in total

1.  Delayed cilioretinal artery occlusion after a hemiretinal vein occlusion.

Authors:  Malavika Subash; Kamaljit S Balaggan; Hadi J Zambarakji
Journal:  Int Ophthalmol       Date:  2011-03-09       Impact factor: 2.031

2.  Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas.

Authors:  Annick Desjardins; David A Reardon; James E Herndon; Jennifer Marcello; Jennifer A Quinn; Jeremy N Rich; Sith Sathornsumetee; Sridharan Gururangan; John Sampson; Leighann Bailey; Darell D Bigner; Allan H Friedman; Henry S Friedman; James J Vredenburgh
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

3.  Intravitreal bevacizumab: an analysis of the evidence.

Authors:  Derrick P Smit; David Meyer
Journal:  Clin Ophthalmol       Date:  2007-09

4.  Changes in retinal thickness are correlated with alterations of electroretinogram in eyes with central retinal artery occlusion.

Authors:  Kei Shinoda; Kisaburo Yamada; Celso S Matsumoto; Kenichi Kimoto; Kazuo Nakatsuka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-19       Impact factor: 3.117

5.  Dexamethasone implant (ozurdex) in a case with unilateral simultaneous central retinal vein and branch retinal artery occlusion.

Authors:  Taylan Ozturk; Omer Takes; A Osman Saatci
Journal:  Case Rep Ophthalmol       Date:  2015-02-23

6.  Central Retinal Artery Occlusion after Rhinoplasty Surgery: A Case Report and Literature Review.

Authors:  Mohammad-Reza Ansari-Astaneh; Fereshteh Raoufi; Saeed Shokoohirad; Naser Shoeibi; Mojtaba Abrishami
Journal:  Case Rep Ophthalmol Med       Date:  2022-03-16

7.  Bilateral Central Retinal Vein Occlusion as a First Presentation of Multiple Myeloma: A Case Report.

Authors:  Michael Andrew Tandlich; Kelly Williamson
Journal:  Clin Pract Cases Emerg Med       Date:  2022-08

Review 8.  Pharmacotherapies for diabetic retinopathy: present and future.

Authors:  Stephen G Schwartz; Harry W Flynn
Journal:  Exp Diabetes Res       Date:  2007

9.  Optical Coherence Tomography Angiography of Combined Central Retinal Artery and Vein Occlusion.

Authors:  Shuo-Chieh Wu; Victor M Villegas; Jaclyn L Kovach
Journal:  Case Rep Ophthalmol Med       Date:  2018-02-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.